Pure Global
NCT06396104

Mobilization With Movement Technique on the Stiffness of Cervical Muscles in Individuals With Mechanical Neck Pain

The Effect of Mobilization With Movement Technique on the Stiffness of Cervical Muscles in Individuals With Mechanical Neck Pain: A Randomized Controlled Trial
Istanbul Gelisim University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neck Pain
Drug/Device/Intervention
Mobilisation with movement
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Istanbul Gelisim University
Location
Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Jan 10, 2024
End date
Jun 30, 2024
Enrollment
40 participants
Primary outcome

Muscle stiffness

Summary

Mobilisation with movement (Mulligan Sustained Natural Apophyseal Glides (SNAG)). method has
 been shown to have significant effects on pain, joint range of motion, and functionality in
 patients with neck pain. However, there is a lack of studies examining the effects of this
 technique on muscle stiffness associated with neck pain. Considering the immediate effects of
 a single session of lumbar SNAG application on lumbar muscle stiffness in patients with low
 back pain, it raises curiosity about the effects it would have on cervical spinal segments
 and surrounding muscles. The aim of this study is to investigate the immediate effects of
 Mulligan SNAG application on muscle stiffness, pain, and joint range of motion in patients
 with mechanical neck pain.

ICD-10 classifications
Injuries to the neckUnspecified injury of neckMultiple injuries of neckOther and unspecified injuries of neckOther specified injuries of neck
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06396104
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06396104 through Pure Global AI's free database. This phase not specified trial is sponsored by Istanbul Gelisim University and is currently Recruiting. The study focuses on Neck Pain. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.